Therapeutic Asset Ratings

13,155 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
FLUOROURACILUM Gallbladder Carcinoma	Lisata Therapeutics, Inc.	P2	B (61)
FLUOROURACILUM Renal Cell Carcinoma	Neonc Technologies, Inc.	P2	B (61)
Furosemide Acute Myeloid Leukemia	Memorial Sloan Kettering Cancer Center	P2	B (61)
GENENTECH TAU PROBE 1 Alzheimer Disease	Washington University School of Medicine	P2	B (61)
Glutathione Parkinson Disease	Gateway Institute for Brain Research	P2	B (61)
Hht Acute Myeloid Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2	B (61)
HUMAN FAECAL MATTER Hepatic Encephalopathy	VA Office of Research and Development	P2	B (61)
Hydroxychloroquine Cutaneous Melanoma	ECOG-ACRIN Cancer Research Group	P2	B (61)
Idarubicin Chronic Myeloid Leukemia	M.D. Anderson Cancer Center	P2	B (61)
Idarubicin Mixed Phenotype Acute Leukemia	Fred Hutchinson Cancer Center	P2	B (61)
IGHV3-6601 (81.4%) -(IGHD) -IGHJ101 (100%), CDR-IMGT [8.7.6] (26-33.51-57.96-101)) (1-112) -Homo sapiens IGHG103v, G1m3>G1m17, nG1m1 CH1 K120, CH3 E12, M14, 8-G1v29 CH2 A84.4 (CH1 R120>K (209) (113-210), hinge 1-15 (211-225), CH2 N84.4>A (292) (226-335), CH3 E12 (351), M14 (353) (336-440), CHS (441-442)) (113-442)], (215-216')-disulfide with L-kappa light chain humanized (1'-216') [V-KAPPA (Homo sapiens IGKV1-501 (85.4%) -IGKJ101 (90.0%) Q120>G (102'), CDR-IMGT [7.3.10] (27'-33'.51'-53'.90'-99')) (1'-109') -Homo sapiens IGKC01 (100%) Km3 A45.1, V101 (C-KAPPA A45.1 (155'), V101 (193')) (110'-216')]; dimer (221-221'':224-224'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, cell line CHO-DG44, non-glycosylated Migraine Disorder	H. Lundbeck A/S	P2	B (61)
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER Metastatic Malignant Neoplasm In The Colon	Centre Georges Francois Leclerc	P2	B (61)
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER Triple-Negative Breast Carcinoma	National Cancer Institute (NCI)	P2	B (61)
ins018_055 Idiopathic Pulmonary Fibrosis	InSilico Medicine Hong Kong Limited	P2	B (61)
Ipilimumab Prostate Adenocarcinoma	M.D. Anderson Cancer Center	P2	B (61)
Irinotecan Non-Small Cell Lung Carcinoma	Jiangsu Hansoh Pharmaceutical Co., Ltd.	P2	B (61)
ISOCYCLOPHOSPHAMIDE Nodal Marginal Zone B-Cell Lymphoma	University of California, Davis	P2	B (61)
Lenvatinib Skin Squamous Cell Carcinoma	Merck Sharp & Dohme LLC	P2	B (61)
Letrozole Neoplasm	TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)	P2	B (61)
Lomustine Malignant Glioma	Actuate Therapeutics Inc.	P2	B (61)
Mebufotenin Cognitive Disorder	Johns Hopkins University	P2	B (61)
MELPHALAN Myelodysplastic Syndrome With Excess Blasts	M.D. Anderson Cancer Center	P2	B (61)
MELPHALAN Myelofibrosis	Center for International Blood and Marrow Transplant Research	P2	B (61)
Mesna Acute Leukemia	Center for International Blood and Marrow Transplant Research	P2	B (61)
METHOTREXATE T-Cell Non-Hodgkin Lymphoma	St. Jude Children's Research Hospital	P2	B (61)

Showing 1426 to 1450 of 13,155 assets

PreviousPage 58 of 527Next